902-430-5022
An Innovative Approach to Delivering Health Care To People With Pain & Addiction
Who We Are
Upcoming Continuing Professional Development Opportunities
Monthly Virtual Learning Webinars
March 21, 2023 @ 7:00pm ADT: Dr. Pamela Arenella will present "Risky Business: Assessment and Management of Self-Harm in your Patients". For login details, please contact Shelley.ledrew@nshealth.ca
Benzodiazepine Use Workshop
June 3, 2023: This accredited half-day workshop taking place in Sydney, NS will cover the when, why, and how to taper, strategies to promote engagement. Seating is limited to 36 participants. For further details use the link
News & Publications
.jpg)
02-06-2023
Nova Scotia Health's Mental Health and Addictions Program is seeking one or two part-time term position of Medical Advisor(s)-Inpatient Addiction Medical Consult Service. For more details click here
12-13-2022
The People in Pain Network (PIPN) support group will be launching a new support group in Sydney, NS beginning in January 2023. For more information please visit the PIPN website.
10-20-2022
Congratulations to AMN-P&A member and Advisory Committee member Josephine Muxlow who has been inducted as a Fellow of the Canadian Academy of Nursing. Fellowship is the highest honour for Canada's most accomplished nursing leaders in clinical practice, education, administration, research and policy.
10-20-2022
AMN-P&A member and Advisory Committee member Virginia McIntyre has been invited as a Person with Lived Experience to join the Canadian Pain Society leadership team. This is the first time in CPS a PWLE is a member of the leadership team. Congratulations Virginia this is fantastic news for those living with pain.
07-05-2022
Congratulations to the Network's Clinical Advisor for Pain and Mentor Dr. Maureen Allen on her new appointment as the Prescription Monitoring Program's Medical Consultant.
07-04-2022
Are doctors still prescribing too many opioids?
A study led by a McGill university scientist suggests opioid painkillers are not always beneficial-and sometimes harmful-as patients recover from a minor surgery. Go to article
06-17-2022
Congratulations to former mentor and leader within the AMN Dr. John Fraser who was awarded the Canadian Medical Association Honorary Membership Award for his dedication and leadership providing care for Nova Scotians living with chronic pain, substance use disorder and homelessness. Read the announcement here
06-06-2022
Congratulations to our own Dr. Leisha Hawker who has been appointed Doctors Nova Scotia's new president. Read the announcement here
05-02-2022
The AMN-P&A is thrilled to partner with @Pain_Canada, a multi-stakeholder, national initiative bringing together diverse people, organizations, and perspectives to work towards dramatically improved systems of care for people with chronic pain. Learn more at paincanada.ca
03-31-2022
New Benzodiazepine Standard
Physicians are aware of the harmful effects of Benzodiazepines and Z-drugs when used long-term or in combination with opioids.
The profession has achieved significant improvement in prescribing Benzodiazepines and Z-Drugs, with a significant reduction in co-prescribing these medications with opioids. Prescribing is particularly challenging when caring for legacy patients and when attempting to taper dosages.
To offer support and direction to physicians, the College’s Council has recently approved a new Professional Standard Regarding Benzodiazepines and Z-Drugs. This new guidance was developed in consultation with stakeholders including Nova Scotia Health, Doctors NS, and CMPA.
The Safer Opioid Prescribing Program
The Nova Scotia Health Authority’s AMN-P&A in partnership with Doctors Nova Scotia is pleased to offer the Safer Opioid Prescribing Program. Developed and presented by the University of Toronto, the course is evidence-based, free of industry conflicts of interest and available to physicians, medical residents and nurse practitioners who prescribe opioids.
AMN-P&A is Supported by
AMN-P&A is Endorsed by
